Novartis to sell 70.68% stake in Novartis India for 14.46 billion rupees
Apr 11, 2026
Novartis agreed to sell its 70.68% stake in Novartis India Ltd. for 14.46 billion rupees. The buyers also launched a 26% open offer at 860.84 rupees per share.
News Related to Waverise Investments
Related coverage linked through entity extraction aliases.
Novartis Exits Indian Subsidiary in $159 Million Stake Sale
Feb 20, 2026
Novartis AG sells 70.7% stake in its Indian unit to a private equity consortium led by WaveRise Investments for $159 million, marking a complete exit from the listed subsidiary while retaining its commercial operations.
Novartis India Surges 20% on Stake Sale; Parent Company Shares Show Strong Momentum
Feb 20, 2026
Novartis India shares hit upper circuit after Swiss parent agreed to sell 70.68% stake to ChrysCapital-led consortium for Rs 1,445.89 crore. Meanwhile, Novartis AG shares have returned 35.5% over one year, trading at CHF126.46.
Novartis Exits Indian Listed Unit With $159 Million Stake Sale
Feb 20, 2026
Novartis AG sells its entire 70.68% stake in Novartis India Ltd. for $159 million to a consortium of investors, concluding a two-year strategic review while maintaining operations through its wholly-owned Indian subsidiary.
Novartis to Exit Indian Unit With $159 Million Stake Sale to PE Consortium
Feb 20, 2026
Swiss drugmaker Novartis will sell its entire 70.68% stake in its listed Indian unit to a private equity consortium for $159 million as part of broader global restructuring. Shares of Novartis India surged nearly 20% following the announcement.
Novartis Shares Hit Record High as Swiss Parent Exits India Unit in $159 Million Deal
Feb 14, 2026
Novartis agrees to sell its 70.68% stake in Indian unit for $159 million to ChrysCapital-led consortium, while parent company shares reach all-time highs with 55% gains over the past year.